For a limited time, patients with a prescription can get a steep discount on the popular medications, as long as they’re ...

Novo Nordisk’s board overhaul signals a decisive return to Foundation-led scientific and operational governance, raising strategic questions about whether the company can sustain U.S. growth and ...

Novo Nordisk plans “all in” launch of Wegovy pill in the US market and will cut price of the drug's injectable option in the ...

Novo Nordisk NOVOb.CO said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers ...

Novo Nordisk offers Ozempic Wegovy sold 199 per month for new self-paying patients from Nov. 17 to March 31 with discounted initial doses.

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without insurance.

The cash price of the popular weight-loss drug Wegovy was lowered by 30% on Monday, now priced at $349, down from $499.

The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for ...

Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

New cash-paying patients can now access Wegovy/Ozempic for $199 a month. Here's what that means for Novo Nordisk stock.